CARLSBAD, Calif.--(BUSINESS WIRE)--Scientists from the Baylor College of Medicine Human Genome Sequencing Center (HGSC) are expanding their fleet of advanced genomic next-generation sequencing technology from Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE) to accelerate their studies of the genetic underpinnings of cancer and other complex human diseases. Additional SOLiD™ Systems will be integrated into the HGSC’s existing base of genomics analysis technologies. With a total of 20 systems, HGSC scientists will use these sequencing platforms to further conduct comprehensive analyses of the genetic changes that characterize cancer, autism and cardiovascular disease in humans.